News

Biologists Discover Source for Boosting Tumor Cell Drug Sensitivity

Gene that inhibits HIV identified as a potential candidate for cancer treatments

DNA-damaging agents, or “DDAs,” make up the most widely used group of cancer drugs. Yet their therapeutic success has been curtailed by drug resistance—either present in cancer cells from the disease onset or arising during treatment.